Zhou A - Search Results

1

TRPV1 SUMOylation suppresses itch by inhibiting TRPV1 interaction with H1 receptors.

Gao Y, Ma R, Weng W, Zhang H, Wang Y, Guo R, Gu X, Yang Y, Yang F, Zhou A, Cheng J, Chen ZY, Zhu MX, Li Y. Gao Y, et al. Among authors: zhou a. Cell Rep. 2022 Jun 14;39(11):110972. doi: 10.1016/j.celrep.2022.110972. Cell Rep. 2022. PMID: 35705043 Free article.

2

14-3-3τ promotes surface expression of Cav2.2 (α1B) Ca2+ channels.

Liu F, Zhou Q, Zhou J, Sun H, Wang Y, Zou X, Feng L, Hou Z, Zhou A, Zhou Y, Li Y. Liu F, et al. Among authors: zhou y, zhou j, zhou q, zhou a. J Biol Chem. 2015 Jan 30;290(5):2689-98. doi: 10.1074/jbc.M114.567800. Epub 2014 Dec 16. J Biol Chem. 2015. PMID: 25516596 Free PMC article.

3

Sequential posttranslational modifications regulate PKC degradation.

Wang Y, Wang Y, Zhang H, Gao Y, Huang C, Zhou A, Zhou Y, Li Y. Wang Y, et al. Among authors: zhou y, zhou a. Mol Biol Cell. 2016 Jan 15;27(2):410-20. doi: 10.1091/mbc.E15-09-0624. Epub 2015 Nov 12. Mol Biol Cell. 2016. PMID: 26564794 Free PMC article.

4

Structural basis of a novel heterodimeric Fc for bispecific antibody production.

Wei H, Cai H, Jin Y, Wang P, Zhang Q, Lin Y, Wang W, Cheng J, Zeng N, Xu T, Zhou A. Wei H, et al. Among authors: zhou a. Oncotarget. 2017 May 2;8(31):51037-51049. doi: 10.18632/oncotarget.17558. eCollection 2017 Aug 1. Oncotarget. 2017. PMID: 28881627 Free PMC article.

5

SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism.

Wang T, Cao Y, Zheng Q, Tu J, Zhou W, He J, Zhong J, Chen Y, Wang J, Cai R, Zuo Y, Wei B, Fan Q, Yang J, Wu Y, Yi J, Li D, Liu M, Wang C, Zhou A, Li Y, Wu X, Yang W, Chin YE, Chen G, Cheng J. Wang T, et al. Among authors: zhou w, zhou a. Mol Cell. 2019 Aug 22;75(4):823-834.e5. doi: 10.1016/j.molcel.2019.06.008. Epub 2019 Jul 10. Mol Cell. 2019. PMID: 31302001 Free article.

6

DUSP6 SUMOylation protects cells from oxidative damage via direct regulation of Drp1 dephosphorylation.

Ma R, Ma L, Weng W, Wang Y, Liu H, Guo R, Gao Y, Tu J, Xu TL, Cheng J, Zhu MX, Zhou A, Li Y. Ma R, et al. Among authors: zhou a. Sci Adv. 2020 Mar 25;6(13):eaaz0361. doi: 10.1126/sciadv.aaz0361. eCollection 2020 Mar. Sci Adv. 2020. PMID: 32232156 Free PMC article.

7

SUMOylation modulates the LIN28A-let-7 signaling pathway in response to cellular stresses in cancer cells.

Dou J, Zhang H, Chen R, Shu Z, Yuan H, Zhao X, Wang Y, Huang J, Zhou A, Yu J. Dou J, et al. Among authors: zhou a. Mol Oncol. 2020 Sep;14(9):2288-2312. doi: 10.1002/1878-0261.12694. Epub 2020 Jun 1. Mol Oncol. 2020. PMID: 32333719 Free PMC article.

8

Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade.

Zhang F, Wei H, Wang X, Bai Y, Wang P, Wu J, Jiang X, Wang Y, Cai H, Xu T, Zhou A. Zhang F, et al. Among authors: zhou a. Cell Discov. 2017 Mar 7;3:17004. doi: 10.1038/celldisc.2017.4. eCollection 2017. Cell Discov. 2017. PMID: 28280600 Free PMC article.

9

Structural mechanism of VWF D'D3 dimer formation.

Shu Z, Zeng J, Xia L, Cai H, Zhou A. Shu Z, et al. Among authors: zhou a. Cell Discov. 2022 Feb 15;8(1):14. doi: 10.1038/s41421-022-00378-2. Cell Discov. 2022. PMID: 35169124 Free PMC article. No abstract available.

10

Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody.

Gao H, Cai H, Liu J, Wang X, Zheng P, Devenport M, Xu T, Dou F, Liu Y, Zhou A. Gao H, et al. Among authors: zhou a. Cell Discov. 2020 Nov 3;6(1):79. doi: 10.1038/s41421-020-00202-9. Cell Discov. 2020. PMID: 33298884 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,214 results

Search Page